Cramer on NVIDIA CEO Exit, Anthropic IPO Risks, and Moderna's Cancer Vaccine Breakthrough
Summary
Jim Cramer discusses the resignation of NVIDIA CEO Jensen Huang amid security and personal scandals, advising investors to take profits despite the company's strong fundamentals. He analyzes Anthropic's upcoming IPO, highlighting concerns about share unlock dynamics and pricing pressure compared to its massive cash balance. The episode also covers Kraft Heinz's strategic pivot away from a corporate split toward innovation and digital marketing. Finally, Cramer highlights Moderna's stock surge following positive melanoma vaccine data and details the company's personalized cancer treatment technology.
Episode sections
- 1:32 – 15:00
NVIDIA CEO Resignation and Market Impact
Jim Cramer discusses the resignation of NVIDIA CEO Jensen Huang, citing security risks and an inappropriate relationship with an executive. He argues that while the scandal is damaging, the company's strong balance sheet and interim CFO suggest the stock should not collapse, though he advises taking profits.
- 15:00 – 24:11
Kraft Heinz Turnaround and Investor Day
Cramer interviews Kraft Heinz CEO Steve Kalman, who explains the decision to abandon a planned split of the company. Kalman highlights investments in innovation, such as high-protein Jell-O and ramen, and a shift toward digital marketing to drive growth.
- 24:11 – 29:28
Anthropic IPO Analysis
Cramer outlines the pros and cons of Anthropic's upcoming IPO, noting its massive cash balance and AI-driven productivity gains as positives, while raising concerns about pricing pressure, regulatory risks, and the need for new hit products beyond coding tools.
- 29:28 – 30:17
Anthropic IPO Float and Lockup Dynamics
The speaker analyzes the initial public offering of Anthropic, noting that the offering represents approximately 6% of shares outstanding, similar to SpaceX. A small tranche of employee shares unlocks on day one, bringing the float to 7%, with the remainder unlocking gradually over the next year via 22 releases, starting less than a month post-IPO.
- 30:17 – 31:17
Historical Comparison to SpaceX IPO Performance
The speaker draws a parallel to SpaceX's IPO, where the stock was squeezed from an IPO price of $135 to a high of $225 on the third day before falling back. The speaker argues that supply and demand dynamics, rather than fundamental deterioration, drove the decline, and warns of similar downward pressure for Anthropic as shares unlock.
- 31:17 – 32:21
Investor Caution on Anthropic and Lam Research Buy
The speaker expresses wariness about buying Anthropic shares initially due to fears of a hot open followed by a drop. In contrast, the speaker identifies Lam Research as a strong buy, citing its excellent management and status as the best in semiconductor capital equipment intellectual property.
- 32:21 – 34:40
Moderna's Financial Surge and Analyst Day
The speaker highlights Moderna's stock performance, noting it rose from $63 on August 18th to over $174 the following day after announcing positive melanoma data with Merck. The stock is up over 680% for 2026, and the company raised its full-year sales forecast following a surprise profit driven by vaccine sales.
- 34:40 – 35:59
Moderna's Personalized Cancer Vaccine Technology
CEO Stéphane Bancel explains the mechanism of Moderna's personalized cancer vaccine, which involves sequencing a patient's tumor and healthy DNA to identify mutations. The resulting product is an individualized mRNA injection containing 34 mutations, administered intramuscularly every three weeks for nine doses to train the immune system's T-cells to fight cancer.
- 35:59 – 41:26
Clinical Data and FDA Filing Timeline
Bancel reports a 42% improvement compared to Keytruda in melanoma treatment and notes that five-year data from a Phase II study shows efficacy improving over time due to T-cell memory. The company aims to file with the FDA before the end of the year, with product availability expected in 2027, while conducting studies in lung, kidney, and bladder cancers.
- 41:26 – 43:03
Lightning Round: Combolt and Bright Horizons
In the Lightning Round, Cramer praises Combolt's CEO and calls the stock a 'good call' despite its recent rise. Conversely, he advises against Bright Horizons (BFAM), describing it as an expensive stock where earnings are unlikely to materialize, and rejects Texas Pacific Land.
- 43:03 – 49:07
Jim Cramer's Tribute to Jensen Huang
Cramer shares personal anecdotes about NVIDIA CEO Jensen Huang, including renaming his dog to NVIDIA and visiting headquarters. He praises Huang's brilliance and graciousness but expresses deep disappointment over recent news, stating that Huang has let down his family, company, shareholders, and the nation's future as an AI leader.
Assets discussed
| Asset | Kind | Stance | Context |
|---|---|---|---|
| NVIDIANVDA | equity | mixed | The ill-advised, not very well, a hidden affair with one of his direct reports, something five NVIDIA The executives confirmed to the New York Times, is flat out against the rules at most companies. and is embarrassingly unprofessional. |
| Anthropic | private company | mixed | Every night this week, I've been spending some time trying to prepare you for next week's historic anthropic IPO. I've been covering this story from all ankles, explaining the stakes and the broad terms of the deal, looking at Anthropic's impressive growth, and examining the company's cost. complicated profitability profile. |
| SpaceX | private company | mixed | The float and its lockup expiration schedule. Important details that will go a long way determining how the stock trades initially. Based on the current numbers, next week's offering represents around 6% of anthropic shares outstanding. Very similar proportion to what we saw from SpaceX in June. The one difference here is that a tranche of |
“Stance” is how the speakers talked about the asset, not a recommendation.
Claims worth verifying
Jensen Wong resigned as CEO of NVIDIA due to security risks and an inappropriate relationship with executive Kimberly Powell.
Unidentified speaker (speaker_3) ·1:32
How to verify: Check NVIDIA's official press release dated November 12, 2026, and the New York Times article referenced by Cramer. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceColette Kress is the current CFO and interim CEO of NVIDIA.
Unidentified speaker (speaker_3) ·4:34
How to verify: Check NVIDIA's investor relations website or recent SEC filings for executive appointments. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceAnthropic had $132 billion in cash, cash equivalents, and short-term investments at the end of September.
Unidentified speaker (speaker_0) ·24:51
How to verify: Review Anthropic's S-1 registration statement filed with the SEC EDGAR database prior to the IPO. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceAnthropic expects to add around $100 billion in cash from its IPO.
Unidentified speaker (speaker_0) ·24:51
How to verify: Check the pricing terms and size of the IPO disclosed in Anthropic's S-1 filing. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary source90% of contributions to Anthropic's code base are written by Claude.
Unidentified speaker (speaker_0) ·25:10
How to verify: Check Anthropic's S-1 filing or official blog posts detailing AI productivity metrics. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceAnthropic saw a 45 times increase in code contributed per engineer from 2024 levels in Q3.
Unidentified speaker (speaker_0) ·25:10
How to verify: Review Anthropic's S-1 filing for operational metrics and growth statistics. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceSteve Kalman bought $5 million of Kraft Heinz shares personally after becoming CEO.
Unidentified speaker (UNKNOWN) ·15:40
How to verify: Check Kraft Heinz Form 4 filings with the SEC for insider stock purchases. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceKraft Heinz expects sales and operating profit to start growing again in the second half of 2027.
Unidentified speaker (speaker_3) ·15:00
How to verify: Review Kraft Heinz's investor day presentation materials or press release from November 12, 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
The Anthropic offering represents around 6% of shares outstanding, with the float rising to 7% on the first day of trading.
Unidentified speaker (speaker_0) ·29:28
How to verify: Check the final prospectus filed by Anthropic with the SEC EDGAR system for the IPO size and percentage of outstanding shares; verify lockup expiration schedules in the prospectus. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceSpaceX stock was squeezed from an IPO price of $135 to a high of $225 on its third day of trading, then fell back.
Unidentified speaker (speaker_0) ·30:17
How to verify: Search historical stock price data for SpaceX (if traded) or verify via financial news archives from June 2026/2026 regarding the SpaceX IPO pricing and trading history. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceModerna stock was $63 on August 18th and closed above $174 the next day.
Unidentified speaker (UNKNOWN) ·32:21
How to verify: Check historical stock price data for Moderna (MRNA) on the NASDAQ exchange for August 18, 2026, and August 19, 2026. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Moderna is up more than 680% for 2026.
Unidentified speaker (speaker_0) ·32:35
How to verify: Calculate the year-to-date percentage change for Moderna (MRNA) stock price from January 1, 2026, to the date of the broadcast (November 12, 2026). For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Moderna and Merck announced that adding their personalized cancer shot to Merck's Keytruda helped keep melanoma from coming back after surgery.
Unidentified speaker (UNKNOWN) ·32:21
How to verify: Search for press releases or SEC filings (Form 8-K) from Moderna and Merck dated around August 2026 announcing the melanoma trial results. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceThe Moderna COVID vaccine dose is one-fifth of the initial dose.
Unidentified speaker (speaker_1) ·33:54
How to verify: Review the FDA approval documents or product inserts for Moderna's updated COVID vaccine (mRNA-1283 or similar) to compare dosing information. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Moderna aims to file with the FDA before the end of the year (2026).
Unidentified speaker (UNKNOWN) ·37:16
How to verify: Monitor FDA press releases or Moderna's investor calendar for submission dates of the BLA (Biologics License Application) for the melanoma vaccine. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Jim Cramer renamed his dog Everest to NVIDIA.
Unidentified speaker (UNKNOWN) ·44:05
How to verify: Verify via Jim Cramer's autobiography, public social media history, or past episodes of Mad Money where he discusses his dog. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceNVIDIA stock was around $4 when Cramer first bought it from his Chapel Trust.
Unidentified speaker (UNKNOWN) ·44:22
How to verify: Check Jim Cramer's public disclosures or past interviews regarding his personal investment history with NVIDIA, cross-referenced with NVIDIA's stock price history. For recent events, verify 2026-08-13 through 2026-11-13. Use another period only when the speaker explicitly names it.
Primary sourceDo your own research
- Review NVIDIA's SEC Form 8-K for the official resignation details and any disclosed investigations into export controls.
- Check Anthropic's S-1 filing for the exact number of shares outstanding, lockup expiration dates, and over-allotment provisions.
- Verify Moderna's Phase II melanoma data in the published clinical trial results or FDA briefing documents.
- Examine Kraft Heinz' latest 10-K or 10-Q for capital allocation plans and the rationale behind abandoning the split.
- Monitor U.S. Department of Commerce export control regulations for any new restrictions on AI chip exports to China.
- Check Lam Research's recent earnings reports and management commentary on semiconductor capital equipment demand.
- Review SpaceX's historical stock performance post-IPO to compare supply/demand dynamics with Anthropic's projected float.
- Verify Steve Kalman's insider trading activity via SEC Form 4 filings for accuracy of the $5 million purchase claim.
Full transcriptexpand
- 0:00
- Unidentified speaker (UNKNOWN): In
- 0:01
- Unidentified speaker (speaker_0): communities across Canada, hourly Amazon employees earn an average of over $26 an hour. Employees also have the opportunity to grow their skills and their paycheck by enrolling in free skills training programs for in-demand fields like software development and information technology.
- 0:22
- Unidentified speaker (speaker_0): Learn more at about aboutAmazon.ca. Amazon.ca
- 0:29
- Unidentified speaker (speaker_1): Holidays calling, holidays calling.
- 0:31
- Unidentified speaker (speaker_2): Hello. Hi
- 0:32
- Unidentified speaker (speaker_1): Deb! It's the holidays calling. It's snowing out and you still have some shopping to do.
- 0:36
- Unidentified speaker (speaker_2): No problem. I have the Kia Sportage X-Line Limited with all-wheel drive for any winter conditions.
- 0:42
- Unidentified speaker (speaker_3): Okay, well, it's really cold out.
- 0:44
- Unidentified speaker (UNKNOWN): I
- 0:44
- Unidentified speaker (speaker_2): have remote start with Kia Connect to pre-warm my Sportage.
- 0:47
- Unidentified speaker (speaker_3): Okay then. Enjoy your warm, comfortable drive. Get a hole.
- 0:50
- Unidentified speaker (speaker_2): holiday bonus of up to $1,000 on Select 2026 Kia Sportage models. See Kia.ca for details. Kia. Movement that inspires.
- 1:01
- Unidentified speaker (speaker_3): My mission is simple: to make you money. I'm here to level the playing field for all investors. There's always a bull market somewhere, summer, and I promise to help you find it. Mad Mab Money starts now.
- 1:17
- Unidentified speaker (speaker_3): Hey, I'm Kramer. Welcome to MAD Money. Welcome to Kramerica. My friends, I'm just trying to make a little bit of money here. My job is not just to entertain, but to do some teaching, so call me at 1-800-743-CBC. Twing me at Jim Kramer.
- 1:31
- Unidentified speaker (UNKNOWN): In
- 1:32
- Unidentified speaker (speaker_3): the end, Jensen Wong was more of a liability to the company he founded and ran than a positive. The possibility of him being a mark for a Chinese spy, giving up key secrets, or even helping them get the latest chips, having them find their way to the People's Republic, cannot be ruled out.
- 1:52
- Unidentified speaker (speaker_3): The ill-advised, not very well, a hidden affair with one of his direct reports, something five NVIDIA The executives confirmed to the New York Times, is flat out against the rules at most companies. and is embarrassingly unprofessional.
- 2:07
- Unidentified speaker (UNKNOWN): So
- 2:07
- Unidentified speaker (speaker_3): his staying on as CEO of NVIDIA, just because he was NVIDIA to many, and the stock price would be much higher if he went removed, simply wasn't an option. This morning he resigned, and yes, he did resign in disgrace. Did we want him to go? If we are shareholders, pre pre-disgrace, disgrace, of course not. He was an amazing.
- 2:27
- Unidentified speaker (speaker_3): CEO. Post-disgrace, knowing what we know now about the way that this brilliant man put the institution he said he loved into jeopardy.
- 2:36
- Unidentified speaker (UNKNOWN): I
- 2:36
- Unidentified speaker (speaker_3): have to say yes, in any case, I don't think the board had any other choice. I'm not a moral morality coach, nor am I a board member of NVIDIA. I IO open Pine on stocks for a living. So in this day where the Dow dipped 189 points, the SB SP fell point three. 0.35%, the NASDAQ dropped 0.39%. We have to figure out what a Jensenless NVIDIA is
- 2:56
- Unidentified speaker (speaker_3): worth. Clinically. First, let's take something I heard all day off the table. He will not be allowed to participate in NVIDIA's affairs, either in a public or or a sidebar fashion. No. Jensen Wong has left the building. The company wants him as far away as possible because it wants to isolate him and keep the multiple
- 3:15
- Unidentified speaker (speaker_3): investigations his actions have caused from tainting the day to day operations of this company. Remember, this the board represents you, not Jensen. It's bad enough that there will be employees investigated to see if they turned a blind eye to what might have been a clear pipeline of high end NVIDIA chips to the PRC via his
- 3:35
- Unidentified speaker (speaker_3): paramour's ties to the Communist Party. There will also have to be an investigation. of the sort of affair Jensen Wong had with Kimberly Powell, NVIDIA's vice president of healthcare. An important position that might not have been handled as well as it should have because of the relationship.
- 3:51
- Unidentified speaker (UNKNOWN): So
- 3:51
- Unidentified speaker (speaker_3): then you'll ask, how come the stock didn't go down even more today? First, I remind you that it's been going down for months, and it's not exactly like it's expensive here. The company reports next week, and I believe it will be a huge. quarter. Remember, this isn't Sendant or Enron or WorldCom. Horrendous financial scandals where there was little to nothing
- 4:11
- Unidentified speaker (speaker_3): in the bank. That's the kind of scandal you must run from no matter what. There's tens of billions of dollars in the bank here, no accounting irregularities. This is a scandal involving potential liability from those orders procured by a spy. And the sanctions. that might be placed on NVIDIA by the government. Something yet is less likely now that Jensen has
- 4:31
- Unidentified speaker (speaker_3): been cut loose.
- 4:34
- Unidentified speaker (speaker_3): Second, the person named Interim CEO, Colette Cress, who is the current CFO. I know people think I was close to Wong and maintain a good relationship, but let me tell you something. My principal contact at the company had been Colette Clette Crest. Cress. She runs the conference call, an amazing conference. call. She's the person who explains things to me and
- 4:53
- Unidentified speaker (speaker_3): answers my questions. Crest knows more about the company than Wong does. Not the technology, but how the company works. She is tough as nails. Yeah, the kinds of nails that come out of a nail gun. To say that she doesn't suffer fools gladly understates her precision and her rigor, and the lack of viewers if you ask something stupid,
- 5:13
- Unidentified speaker (speaker_3): which I have done and regret it. regretted immediately. She will hold things together well in the interim. And with Crest at the helm, the idea that there is a financial scandal of the kind that makes you have to sell the stock just goes away. Because she is the keeper of the numbers. She will be on full display when they report next Tuesday, as she always is on the conference calls.
- 5:33
- Unidentified speaker (speaker_3): I say bravo. The last reason that the market didn't fall apart today is the upcoming anthropic idea. IPO. We're on the verge of what might be the biggest IPO of all time. And the ramifications for the semi, especially NVIDIA, and that the ecosystem that Jensen created with all his investments are now going to pay off. They maybe actually be able to recoup most of those investments once this
- 5:53
- Unidentified speaker (speaker_3): happens. Now remember your cross-disciplines here, people. As I told CMUC Investing Club members today during our morning meeting streaming show at 1020, if you're one of the myriad inviting NVIDIA millionaires the club and Jensen Wong created, thank you, Jensen, for doing that. You need to be sure you take at least some of those profits off the table. Don't ever turn a
- 6:13
- Unidentified speaker (speaker_3): successful investment into an unsuccessful trade, no matter who it's with. We don't know what else is going to come out from what will almost certainly be multiple investigations. Whatever it is, I don't think it's gonna be any good. You don't want to give up all of your gains if the stock falls further. It fell further today after many of the analysts jumped ship and downgraded the stock from buy
- 6:33
- Unidentified speaker (speaker_3): to hold. But I think there could be many more of those ahead. We don't know what NVIDIA's competitor is going to do. We know that AMD has been catching up with its own product lines. Broadcom's quite competitive. Google and Amazon less so, but Amazon does have what may soon be a $50 billion semiconductor business. That's the second half of 27. Can they catch up? to NVIDIA with its clear
- 6:52
- Unidentified speaker (speaker_3): four-year product roadmap? If you think, as the analysts seem to believe, that the other 42,000 other employees don't matter much,
- 7:02
- Unidentified speaker (UNKNOWN): then
- 7:02
- Unidentified speaker (speaker_3): you're gonna get cold feet, even if you see the great numbers next Tuesday. I can hear the razzing about last good quarter all over the place. We know that the investigations might lead to international export curtailments, which would would hurt. the business and lead to number cuts. That means that no matter how low the price journeys multiple gets, the stock could still go lower.
- 7:21
- Unidentified speaker (UNKNOWN): So
- 7:22
- Unidentified speaker (speaker_3): where do I come out? We've made, you know, look, we've made fortunes in NVIDIA for the Chavel Trust, but we still have too much with the stock here at 166. That means it cuts to selling some when we are not restricted from doing so. And we've been restricted for ages and ages and had to ride. this one down. But here's something you might be
- 7:41
- Unidentified speaker (speaker_3): happy about. I did a small canvas today of executives who I thought could be the Tim Cook to Jensen Steve Jobs. Tall order, as Cook was a first ballot Hall of Famer. But the caliber of candidates here who are interested in this job made me feel that there won't be a better NVIDIA, just
- 8:01
- Unidentified speaker (speaker_3): a different one. One that is better organized, perhaps, and not just throwing money around to wrap up companies in an NVIDIA ecosystem. Maybe we'll get someone who decides it's okay to take profits on the company's successful investments in other companies. Now that the anthropic deal will liquefy the ecosystem that Jensen Mont created. Maybe we'll have a CEO who
- 8:21
- Unidentified speaker (speaker_3): does more to highlight the company's other 42,000 employees, the ones whom I think are insulted by what's happening, the ones that don't wear the leather jackets. They exist too. The bottom line: am I mad about Jensen? Yes. I liked him so damn much. I am crushed by this.
- 8:40
- Unidentified speaker (UNKNOWN): I
- 8:40
- Unidentified speaker (speaker_3): thought he was a better guy. Did he betray me? Nah, no. It's my job to not be betrayed, to be smarter, to have my eyes more more wide open. He didn't betray me. Did
- 8:50
- Unidentified speaker (UNKNOWN): he
- 8:50
- Unidentified speaker (speaker_3): betray you? the shareholders? Yeah.
- 8:53
- Unidentified speaker (UNKNOWN): And
- 8:53
- Unidentified speaker (speaker_3): a story. Dennis in Ohio. Dennis.
- 8:56
- Unidentified speaker (speaker_1): Hey, how are you, Jim?
- 8:58
- Unidentified speaker (speaker_3): Dennis, I'm okay. How about you?
- 9:00
- Unidentified speaker (UNKNOWN): Hey,
- 9:00
- Unidentified speaker (speaker_1): I woke up today, so it's a good day, right?
- 9:03
- Unidentified speaker (speaker_3): You know what? I actually said that this morning, so yeah. The answer is yeah to that. Okay.
- 9:09
- Unidentified speaker (speaker_1): Hey, I'm calling on Sinoco. It's gone from uh eighty in August down in the low sixties now.
- 9:14
- Unidentified speaker (speaker_3): Yeah.
- 9:15
- Unidentified speaker (speaker_1): They're having a having another record year,
- 9:17
- Unidentified speaker (UNKNOWN): uh
- 9:17
- Unidentified speaker (speaker_1): keep raising their dividends, low PE ratio. I just don't get it.
- 9:22
- Unidentified speaker (UNKNOWN): No, I
- 9:22
- Unidentified speaker (speaker_3): like it. Well, it's it's going down because people feel the war's over. I I remember the day I came public and I thought, what a great idea, but then ago I was a s a son of you know, I grew up in Philadelphia. I think this thing's a great piece of paper. I think you're in good shape. Just owing own it. If it goes down to six percent by more. Let's go to Robert in New York who's Please, Robert.
- 9:39
- Unidentified speaker (speaker_1): Jim, so nice to hear your voice and how positive you are. And I got to tell you something. You're doing a great job for us with the ups and downs. You're making us steady and you're basically telling us what to do, which is nibble away at some of the stocks going down. And in the end, it doesn't matter because this has happened 50 times throughout Wall
- 9:59
- Unidentified speaker (speaker_1): Street, where the market has corrected up 10%, down 15%. So if you play the Kramer rule, which is how to make money in any market, you can't lose in the end.
- 10:11
- Unidentified speaker (UNKNOWN): You can't see
- 10:11
- Unidentified speaker (speaker_3): right now, but I'm walking down a street right now that I walked down in nineteen eighty one when the Dow was at a thousand, and everyone told me it is so ridiculously overvalued. Keep your money in C CDs. Ds. I didn't know what a C D was, but I knew what a stock was, so I crushed it. All right, so go ahead. I'm sorry.
- 10:27
- Unidentified speaker (speaker_1): You cr that's why you are the top guy on Wall Street.
- 10:31
- Unidentified speaker (UNKNOWN): That's why you're here to help you.
- 10:32
- Unidentified speaker (speaker_3): And there's like
- 10:32
- Unidentified speaker (UNKNOWN): guys who are billionaires, and they're like, all we
- 10:34
- Unidentified speaker (speaker_3): do is hear from them, and they're fantastic
- 10:36
- Unidentified speaker (UNKNOWN): because when you're a billionaire,
- 10:37
- Unidentified speaker (speaker_3): you're fantastic. Just kidding.
- 10:39
- Unidentified speaker (speaker_1): You're fantastic because you helped the common man.
- 10:42
- Unidentified speaker (UNKNOWN): No, I did good. That's
- 10:43
- Unidentified speaker (speaker_3): what I want. That's what Emma wants me to do. That's my daughter. Good go ahead.
- 10:47
- Unidentified speaker (speaker_1): She's great, your daughter. Phenomenal. But
- 10:49
- Unidentified speaker (UNKNOWN): anyway, I like the full falls and
- 10:51
- Unidentified speaker (speaker_3): potato chips. Yeah.
- 10:52
- Unidentified speaker (speaker_1): Let's make the let's make the listeners some money, or you
- 10:55
- Unidentified speaker (UNKNOWN): tell
- 10:56
- Unidentified speaker (speaker_1): me if I'm wrong here. Okay.
- 10:57
- Unidentified speaker (UNKNOWN): This
- 10:57
- Unidentified speaker (speaker_1): next company's latest results show a sharp earnings reset with weak appliance demand, inflation, and housing softness, pressuring the sales and the margins. Now the management is relying on price increases, manufacturing changes, and a two $290 hundred and ninety million dollar structural savings to support a profitability recovery. in 2027. Now I own this stock, I
- 11:17
- Unidentified speaker (speaker_1): bought it when the earnings got tousted. I met this guy out. He used to work for the company. He goes, This is a good company down the road.
- 11:24
- Unidentified speaker (UNKNOWN): It shouldn't be this
- 11:25
- Unidentified speaker (speaker_1): cheap.
- 11:33
- Unidentified speaker (speaker_3): A kind of a CEO refresh Because the someone has to pay for that decline. And I think it has to be the CEO. I like the guy very much, but the decline is too much. I thank you for your kind words. If I help the comment for the regular person, that's a heck of a lot better than helping all the billionaires I used to help. They were never that appreciative anyway.
- 11:53
- Unidentified speaker (speaker_3): Anyway, on May Money Tonight, Kraft Heinz gave a very optimistic investor Yesterday day presentation. It's is going to ring today's MYSE bell. I'm finding out more about the path for package goods. with the CEO who might just think is great. Then I'm rounding out my series on anthropics, hotly anticipated IPO, with look at some of the more unusual aspects of the deal that you need to know about. And
- 12:13
- Unidentified speaker (speaker_3): Moderna's promising cancer vaccine has been propelling the stock higher this year. What else is in the pipeline? I'm gonna find out with a company CEO. So stay with Craig. Kramer.
- 12:29
- Unidentified speaker (UNKNOWN): Don't miss a second of Mad Money. Follow at Jim Kramer on X. Have a question? Tweet Kramer. Hashtag MadMentions. Send Jim an email to madmoney at cnbc.com. Or give us a call at
- 12:42
- Unidentified speaker (speaker_0): 1-800-743-CNBC.
- 12:45
- Unidentified speaker (UNKNOWN): Miss something?
- 12:46
- Unidentified speaker (speaker_0): Head to madmoney.cnbc.com.
- 12:56
- Unidentified speaker (speaker_2): Legendary has arrived in Alberta with BetMGM Casino. Sign up to unlock access to over 4,000 casino games, including exclusive slots you can't spin anywhere else. Survivors? Ready? The iconic TV show is now an online casino game where you can tap into island fun. BetMGM Howard. has also brought the Prices Right, Game
- 13:16
- Unidentified speaker (speaker_2): of Thrones, Family Feud, MGM Millions, and so many more exclusive casino games to Alberta. Get Las Vegas right from your phone with live dealer games streaming from real tables. And every time you play, you can enjoy instant deposit options and fast withdrawals. BetMGM Casino and its legendary library of games are available. Download the BetMGM app. See
- 13:36
- Unidentified speaker (speaker_2): BetMGM.com for terms. 18 plus Alberta. only. Please play responsibly, subject to eligibility requirements.
- 13:42
- Unidentified speaker (UNKNOWN): If
- 13:42
- Unidentified speaker (speaker_0): gambling is affecting your mental health or well-being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta iGaming Corporation. Standard message and data rates may apply.
- 13:55
- Unidentified speaker (speaker_3): Holidays
- 13:55
- Unidentified speaker (UNKNOWN): calling, holidays calling. Hello. Hi Hey Deb! It's the holidays calling. It's snowing out, and you still have some shopping to do?
- 14:01
- Unidentified speaker (speaker_0): No problem. I have the key Kia of. Sportage X-Line Limited with all-wheel drive for any winter conditions.
- 14:07
- Unidentified speaker (speaker_3): Okay, well, it's really cold out.
- 14:09
- Unidentified speaker (speaker_0): I have remote start with Kia Connect to pre-warm my Sportage.
- 14:13
- Unidentified speaker (speaker_3): Okay then. Enjoy your warm, comfortable drive.
- 14:15
- Unidentified speaker (speaker_0): Get a holiday bonus of up to $1,000 on Select 2026 Kia Sportage models. See Kia.ca for details. Kia. Movement that inspires.
- 14:25
- Unidentified speaker (speaker_2): AI is here. transforming how we work, live, and lead. And the women I talk to aren't waiting for the future, they're shaping it. I'm Julia Borstin, Senior Media and Tech Correspondent at CNBC. This is CNBC Changemakers, where I talk with the female leaders transforming business as AI reshapes the world.
- 14:45
- Unidentified speaker (speaker_2): Follow and listen to CNBC Changemakers, women leading in the age of AI. Wherever you go. get your podcasts.
- 15:00
- Unidentified speaker (speaker_3): This will be exciting, and it's not about NVIDIA. This morning, Kraft Heinz, the Package Food Giant, rang the opening bell to celebrate the move from the Nasdaq to neurostation. Then it's a terrific investor day. The company said it expects sales and operating profit to start growing again. in the second half of next year. She's consistent in accelerating growth by 2029. Since taking the
- 15:20
- Unidentified speaker (speaker_3): helm nearly a year ago, CEO Steve Kaylane has invested 700 million into the business, hired 400 new employees. This is so different from the old one. Let's check in with Steve, the CEO of Craft Plan, to find out more about his comeback plan. Steve, I am so glad to see you're here, and I just said um how much you invest in the company. But let's just get started by how
- 15:38
- Unidentified speaker (UNKNOWN): you're talking about the company
- 15:39
- Unidentified speaker (speaker_3): much have you invested yourself?
- 15:40
- Unidentified speaker (UNKNOWN): Well, thanks for having me, Jim. It's
- 15:42
- Unidentified speaker (speaker_0): always
- 15:42
- Unidentified speaker (UNKNOWN): so shortly after I started with the company, obviously I'm
- 15:45
- Unidentified speaker (speaker_1): paid a
- 15:45
- Unidentified speaker (UNKNOWN): lot
- 15:46
- Unidentified speaker (speaker_1): in uh in in stock,
- 15:47
- Unidentified speaker (UNKNOWN): but I went into the open market and bought five million dollars worth of
- 15:50
- Unidentified speaker (speaker_1): Kraft Hein shares because I like to put
- 15:51
- Unidentified speaker (UNKNOWN): my
- 15:52
- Unidentified speaker (speaker_3): money where my mouth is.
- 15:55
- Unidentified speaker (speaker_3): I know you sure do. I was going through your amazing deck and you s had this line. I think it kind of epitomizes where we are. We always had the right. assets to win. Now we are realizing their full potential. Those assets are pretty great, aren't they?
- 16:08
- Unidentified speaker (speaker_1): They're fantastic. Think about the Heinz brand. I mean, Heinz is loved everywhere around the world, rejected nowhere. We've got a huge opportunity to grow Heinz in its home market of the United States, which
- 16:19
- Unidentified speaker (speaker_0): we've returned it to growth. We've got huge opportunities all around the world. Heinz in Brazil is doing phenomenally well. Heinz in China is opening up whole new occasions with eggs and breakfast. And so Heinz plays everywhere. Heinz soup has just been introduced in Canada. It's off to a flying start. So Heinz is a
- 16:38
- Unidentified speaker (speaker_0): phenomenal brand and it it really is gold.
- 16:41
- Unidentified speaker (speaker_3): Now you are actually reaching people differently from just traditional advertising. You've embraced the channels that I always thought people should start embracing, Meta and TikTok.
- 16:50
- Unidentified speaker (UNKNOWN): Yeah,
- 16:51
- Unidentified speaker (speaker_1): there's no question. Look, today's consumer shows up differently than they did historically. You still have to be in historic, traditional places, but we have to be where the consumer are. We have to go meet the consumer where they are. That's social, that's digital, and the future is it's agentic as well. So we have to continue to evolve our capabilities, we have to invest in our
- 17:11
- Unidentified speaker (speaker_1): capabilities, and we have to meet the consumer where they are.
- 17:13
- Unidentified speaker (speaker_3): State of the consumer seems to be able to buy both your highest end products and your more middling products. Right. Yeah, I think you know the consumer right now, it stopped getting worse, right? The consumer's not in a great spot, uh, but they're not in a terrible spot. The job market's strong, uh, you know, inflation is still a little too challenging, gas prices a little too challenging. But
- 17:33
- Unidentified speaker (speaker_3): you know, we're a staple in many, many cases, and we're a treat in other cases. But we've been able to connect with consumers, hold up our business, improve our trends uh in this country and around the world. And we expect into next year, probably the first half of 27 is still gonna be somewhat of a challenge, a
- 17:50
- Unidentified speaker (UNKNOWN): little bit more inflation.
- 17:51
- Unidentified speaker (speaker_3): That's okay. That's okay. That's okay. The back half of 27, we start to see a lot more, uh, a lot more opportunities to really get ourselves back to group. growth. Well, one of these besides the ex the moving to the exchange that I wouldn't wanted have to you on. was that I've always liked your work, but I did doubt you in Kellogg. I thought that Kellogg were
- 18:08
- Unidentified speaker (speaker_0): dead brands, that there was nothing
- 18:09
- Unidentified speaker (speaker_3): there. I didn't do it on air, but uh
- 18:12
- Unidentified speaker (UNKNOWN): you
- 18:13
- Unidentified speaker (speaker_3): uh did something
- 18:14
- Unidentified speaker (UNKNOWN): rather
- 18:14
- Unidentified speaker (speaker_3): remarkable,
- 18:14
- Unidentified speaker (UNKNOWN): Kellogg. You
- 18:15
- Unidentified speaker (speaker_3): created a huge
- 18:16
- Unidentified speaker (UNKNOWN): amount of
- 18:16
- Unidentified speaker (speaker_3): wealth. How
- 18:17
- Unidentified speaker (UNKNOWN): did you
- 18:18
- Unidentified speaker (speaker_0): go about doing that when other people didn't see anything?
- 18:21
- Unidentified speaker (speaker_3): Well, I think the mistake that was made at Kraft Heinz before I arrived in the last several years is this. notion that there's a forever brand, that brands can just live on the history of their past. That's not true. But equally brands that are existed for a long time are not necessarily destined for the dustbin of history. And that's what a lot of people thought about the
- 18:41
- Unidentified speaker (speaker_3): brands at Kraft Heinz, and they're simply not. When you look at Heinz, which I've already talked about, but Kraft mac and cheese, people said ninety 90 years old, best days are past. new innovation is coming from smaller companies, best days are well.
- 19:04
- Unidentified speaker (speaker_3): And in Canada, we launched a ramen, a cheesy ramen.
- 19:09
- Unidentified speaker (speaker_3): Under the KD. Now I
- 19:10
- Unidentified speaker (UNKNOWN): saw that, I
- 19:10
- Unidentified speaker (speaker_0): said, you gotta be kidding me.
- 19:12
- Unidentified speaker (speaker_3): We sold out uh three months worth of stock in a week. We're gonna introduce that next year. So you have to innovate, you have to bring new news, you have to bring excitement with your brands.
- 19:21
- Unidentified speaker (UNKNOWN): So is high pre
- 19:22
- Unidentified speaker (speaker_0): high protein jello, is that gonna be in in a a Costco or a Walmart?
- 19:26
- Unidentified speaker (UNKNOWN): Sure.
- 19:26
- Unidentified speaker (speaker_3): Yeah, absolutely. And it tastes delicious. You know, one of the problems with protein is you can't necessarily it doesn't go with everything. It's hard to match the flavors. Sometimes it's chalky, sometimes it's off-putting to uh you know putting
- 19:38
- Unidentified speaker (UNKNOWN): it in the room.
- 19:38
- Unidentified speaker (speaker_3): put into existing brands. But our RD team has cracked the code. The chocolate's my favorite. Chocolate jello pudding with protein, I think, is going to be a real hit.
- 19:48
- Unidentified speaker (speaker_0): Okay, so Philadelphia cream cheese, a nice brand. Always felt that it was undermarketed, underdone. Are you blowing it out?
- 19:55
- Unidentified speaker (speaker_3): Yeah, so Philadelphia Cream Cheese is a phenomenal brand. We're doing a lot, especially next year. And it's going to be protein. led as well. We've got a big opportunity to drive protein, to steal some share from cottage cheese. And that's going to come through the Philadelphia name. We're going to do other things in the back half of next year that I think will
- 20:15
- Unidentified speaker (speaker_3): be equally as exciting. But it's a it's one of our biggest share gainers this year, Philadelphia Cream Cheese.
- 20:20
- Unidentified speaker (speaker_0): Now, people wanted before you know the original plan was to split the company in two. What did you see that you knew that wasn't really? right?
- 20:28
- Unidentified speaker (speaker_3): I saw a lot that was fixable. I saw a lot of own goals that we had done. And if we spent all of this year separating the business into two separate companies, we would have continued to underinvest in it, and we would have invested in the wrong things, which are bankers and lawyers to separate the business, we would have ended up with two suboptimal businesses.
- 20:48
- Unidentified speaker (speaker_3): By pausing that and by stopping it, and by putting
- 20:50
- Unidentified speaker (UNKNOWN): the business.
- 20:51
- Unidentified speaker (speaker_3): 700 incremental dollars on top of what we're already spending against the brands, I thought we'd be one bigger, stronger company. The other thing that a lot of businesses like ours have forgotten about is scale can be an advantage, but you have to know what to do with that scale. And so we were going to cut the company in half and become subscale,
- 21:11
- Unidentified speaker (speaker_3): but instead we're a $25 billion business that's going to be growing. again. That's much more power powerful than two businesses that are separated, that are suboptimal, that are not growing.
- 21:20
- Unidentified speaker (speaker_0): All right, last question for you, Steve. Is is that I did you mention about the the brands or forever brands. I do think that certain brands, I thought, had aged out. I thought that both Kraft and Heinz had aged out. That's clearly not the case.
- 21:35
- Unidentified speaker (speaker_3): It's not the case. And I'll give you an example. Okay, So we we rang the bell of the stock. exchange this morning. Before that, we were outside, you know, it was all wonderful. We had the Kool-Aid Man outside. We had a crowd of New Yorkers so excited about seeing the Kool-Aid Man. Right. They'll buy the t-shirt, but we have to contemporize it. We have to innovate.
- 21:57
- Unidentified speaker (speaker_3): Because the brand's loved.
- 21:58
- Unidentified speaker (speaker_0): You sound as fired up as when you did the Kellogg, one of the
- 22:02
- Unidentified speaker (UNKNOWN): greatest trades ever.
- 22:03
- Unidentified speaker (speaker_3): It's a great company. It's an important company. It deserves a bright future. And that's what my team and I are bound and determined to deliver: a bright future for Kraft Heinz.
- 22:12
- Unidentified speaker (speaker_0): I gotta go all in because I I I I've seen you do it once, I think you're gonna do it again.
- 22:17
- Unidentified speaker (UNKNOWN): Thank you.
- 22:21
- Unidentified speaker (speaker_0): But guys, I often point to decks and they're hard to understand. Is there really anything hard to understand? about ketchup and Philly cream cheese? No, Bad Money's back after the break. Thank you, Steve.
- 22:32
- Unidentified speaker (speaker_3): Thanks, Jim.
- 22:34
- Unidentified speaker (speaker_3): Coming up, Kramer's wrapping up his anthropic IPO series by identifying what else you need to know beyond the company's financials. Next.
- 22:49
- Unidentified speaker (speaker_2): Legendary has a arrived in Alberta with BetMGM Casino. Sign up to unlock access to over 4,000 casino games, including exclusive slots you can't spin anywhere else. Survivors, ready? The iconic TV show is now an online casino game where you can tap into island fun. BetMGM has also brought the prices right, Game
- 23:09
- Unidentified speaker (speaker_2): of Thrones, Family Feud, MGM millions, and so many more exclusive casino games to Alberta. Get Las Vegas right from your phone with live dealer games streaming from real tables. And every time you play, you can enjoy instant deposit options and fast withdrawals. BetMGM Casino and its legendary library of games are available. Download the BetMGM app. See
- 23:28
- Unidentified speaker (speaker_2): BetMGM.com for terms. 18 plus Alberta only. Please play responsibly, subject to eligibility requirements.
- 23:35
- Unidentified speaker (UNKNOWN): If
- 23:35
- Unidentified speaker (speaker_0): gambling is affecting your mental health or well well-being, being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta IGaming Corporation. Standard message and data rates may apply.
- 23:48
- Unidentified speaker (speaker_3): Which NHL teams are scoring big off the ice. CNBC Sports Michael Ozanian has the numbers. If
- 23:54
- Unidentified speaker (speaker_0): a DO margin in the NHL is right there with the NBA.
- 23:57
- Unidentified speaker (speaker_3): Official NHL team valuations. See the full list at CNBC.com slash sport.
- 24:11
- Unidentified speaker (speaker_0): Every night this week, I've been spending some time trying to prepare you for next week's historic anthropic IPO. I've been covering this story from all ankles, explaining the stakes and the broad terms of the deal, looking at Anthropic's impressive growth, and examining the company's cost. complicated profitability profile. Tonight I want to wrap things up for
- 24:31
- Unidentified speaker (speaker_0): this Know Your IPO series with a quick run through of all sorts of other considerations for this Anthropic deal, things that aren't reflected in the company's financials, which is what I've focused on so far. I'm gonna start with the pros. And the first thing to call out is the huge cash balance that Anthropic will have after its IPO. I've noted that the company had $132 billion in
- 24:51
- Unidentified speaker (speaker_0): cash, cash equivalents, and short-term investments at the end of September. And it could add around $100 billion in cash from next week's offering. Now, we do know that they're going to need that cash with some $900 billion in compute commitments on the horizon. That's a great buffer to start. Another thing I like is the fact that 90% of contributions to
- 25:10
- Unidentified speaker (speaker_0): Anthropic's code base are actually being written by Claude at this point. Just in the third quarter, Anthropic saw a 45 times increase in code contributed per engineer from 2024 levels. That's called productivity. In other words, the product is increasingly making itself and also finding ways to improve itself. For example, using compute more
- 25:30
- Unidentified speaker (speaker_0): efficiently. This has all sorts of positive benefits. It makes Anthropic more efficient, of course. I don't think it's a coincidence that the company reached profitability at least. on an adjusted basis, as this has happened. And it allows Anthropic to build new models and products faster. All right, now to the open questions. The first one's about pricing. Anthropic has been cutting
- 25:50
- Unidentified speaker (speaker_0): prices for many of its models recently, which some have seen as a bearish development and acknowledgement that customers are chafing at their clawed Claude bills and looking for other options, like the open weight models. that are so inexpensive. That said, I was encouraged to see that Anthropic's revenue growth remained strong in October after many of these price cuts went through. So
- 26:10
- Unidentified speaker (speaker_0): hey, they may have the sweetened right. Companies finding other ways to boost revenues as it cuts space prices, like adding surcharges. It's actually speed surcharges, and lower prices might be encouraging more overall use of Claude. Still, I'm gonna watch the next few months closely to see how these price cuts.
- 26:27
- Unidentified speaker (speaker_0): impact the business.
- 26:29
- Unidentified speaker (UNKNOWN): Now,
- 26:29
- Unidentified speaker (speaker_0): the next question: What's the next big use case going to be? I've told you that the extreme growth for anthropic recently has come from primarily code, Claude Code, okay? The company's coding agent gaining traction in the enterprise. And I still think Claude Code has plenty of growth
- 26:49
- Unidentified speaker (speaker_0): ahead. But for anthropic, Anthropic's revenue to reach the levels it needs to, and there's some incredible levels that they gotta reach. I want to see more hit products from the company. Anthropic debuted the next major product, Claude Co-Work, earlier this year. And they offer some compelling stats about
- 27:04
- Unidentified speaker (speaker_0): revenue ramping for co-work that much, much more quickly than it did for Claude Code. They also rolled the out the industry-specific tools, and just this week, Anthropic analysis. announced some new products that intended to take one Microsoft office. Hey, maybe those catch on. But what are the use cases that are going to lead to the next $100 billion in revenue for
- 27:24
- Unidentified speaker (speaker_0): Anthropic? It might be cybersecurity, given how good Claude is, its body code vulnerabilities. Anthropic also says that life sciences and robotics could be major Major at and markets. But we'll have to see if those things pan out as well as they ex expect. them to. Finally, for the unknowns, how is Anthropic's safety ethos going
- 27:44
- Unidentified speaker (speaker_0): to impact the story? Anthropic CEO Dario Amade loves to remind everyone periodically about how dangerous frontier AI models can be. If he is serious about pacing the frontier, is that negative for revenue growth? But Athropic Anthropic has also built its brain brand around safety. And perhaps that's an absolute asset in a world where customers are both
- 28:04
- Unidentified speaker (speaker_0): eager to adopt AI for their business and somewhat wary of it. I don't know, a little contradictory to me though. That leads directly to my first con. Remember, I did the pros, here's the cons, which is the question of regulation and even potential liability. On the regulatory front, we've already seen this year that a new precedent has been set where the leading AI labs have
- 28:24
- Unidentified speaker (speaker_0): to work with the government before releasing new. frontier models. And after last year's election, I also wonder whether more Democrats in Washington is a bad thing for the AI industry. Soon we'll look to 2028 and speculate about what a new, less AI-friendly administration really might mean.
- 28:42
- Unidentified speaker (UNKNOWN): For
- 28:43
- Unidentified speaker (speaker_0): now, I just worry that there will be more regulatory constraints for the company, either at the infrastructure level or at its for its more powerful new models. As for liabilities,
- 28:53
- Unidentified speaker (speaker_0): I see here there's some issues. Either that an anthropic model is used for some major cyber attack, and that creates legal risk for the company, or as the company's models get increasingly autonomous, they do something they shouldn't, which negatively impacts the customer. Now, I'll add here that I think these regulatory and liability risks
- 29:13
- Unidentified speaker (speaker_0): are more of a concern for OpenAI than they are for. anthropic, given the latter safety first culture. But they are still risks you need to consider for this first major AI IPO. Finally, I want to talk about the company's float. And you got to pay attention. This is the biggest issue for
- 29:27
- Unidentified speaker (UNKNOWN): me.
- 29:28
- Unidentified speaker (speaker_0): The float and its lockup expiration schedule. Important details that will go a long way determining how the stock trades initially. Based on the current numbers, next week's offering represents around 6% of anthropic shares outstanding. Very similar proportion to what we saw from SpaceX in June. The one difference here is that a tranche of
- 29:48
- Unidentified speaker (speaker_0): shares from non-founder employees will be unlocked on the first day of trading. That would bring Anthropics float up to around 7% on the first day of trading.
- 29:57
- Unidentified speaker (UNKNOWN): But
- 29:58
- Unidentified speaker (speaker_0): that's still very small. The rest of the shares will be unlocked gradually over the course of the next year via a series of 22 different lockup releases, which start less than a month after the IPO. The concern here is that we will see a big pop initially as excited investors are competing for a small number of shares. Then, as more shares get unlocked
- 30:17
- Unidentified speaker (speaker_0): every few weeks, that's gonna put downward pressure on Anthropics. The people who are too eager, they get hurt. Basically, I fear they're gonna see a repeat of what happened with SpaceX where the stock squish. squeezed from its IPI price of $135 to a high of $225 on its third day of trading, then came right back down. SpaceX hasn't come close to that initial high since then,
- 30:37
- Unidentified speaker (speaker_0): but not because the story hasn't gotten better. I'd argue it has. It's just supply and demand. Unfortunately, as I told you last Friday, there's still many more SpaceX shares that have yet to be unlocked. So there you go. There are all kinds of unique considerations. for this anthropic deal. Some are positive, some are negative, and some are legitimate open questions. Just things I'm not sure about. I'll have more
- 30:57
- Unidentified speaker (speaker_0): on the deal next week, of course. But for now, I hope this series that we have run has you feeling more informed about whether to participate in this historic IPO. Here's the bottom line: when the deal terms are finalized next week, I'm gonna give you my more formal opinion on whether you should buy in. anthropic shares initially or not. For now,
- 31:17
- Unidentified speaker (speaker_0): I'll just tell you that I'm wary of doing so. Why? Well, because I I fear a hot open. But either way, this is the deal to watch. Let's take some calls. Let's go to Mark in Michigan. Mark.
- 31:31
- Unidentified speaker (speaker_1): Mr. Kramer, it's an honor to speak with you, sir.
- 31:34
- Unidentified speaker (speaker_0): Oh, thank you, Mark. What's happening?
- 31:37
- Unidentified speaker (UNKNOWN): Oh Uh
- 31:37
- Unidentified speaker (speaker_1): well, I've heard you talk a lot about Lamb research, and I'm wondering if at this point it's a good entry point.
- 31:43
- Unidentified speaker (UNKNOWN): I think it is.
- 31:43
- Unidentified speaker (speaker_0): I think it's come down enough. I think Tim Archer does a terrific job. It is absolutely my favorite. Remember, all the intellectual property when it comes to semiconductors really is from the semiconductor capital equipment, and Lamb's got the best. All right, much more man money ahead, including my exclusive with Moderna. Then, like I said earlier, I am deeply saddened by the news out of NVIDIA. I'm leaving you with a few. more
- 32:03
- Unidentified speaker (speaker_0): thoughts, some a degree caustic, about the situation. And Oil Falls rapid fire tonight's edition of the Lightning Round. So stay with Cream Cream.
- 32:21
- Unidentified speaker (UNKNOWN): When
- 32:21
- Unidentified speaker (speaker_0): you look at the stock of Moderna Go. On August 18th, Moderna was a $63 stock. The next day it closed above 174 after Moderna and Merck announced that adding their personalized cancer shot to Merck's Keith
- 32:35
- Unidentified speaker (speaker_0): helped keep melanoma from coming back after surgery. Moderna is now up more than 680% for 2026. It did fall 7% today though. Last week's strong vaccine sales helped Moderna turn a surprise profit, and the company raised its full year. full-year sales forecast. Today, Moderna held this analyst day at the Massachusetts plan that's
- 32:55
- Unidentified speaker (speaker_0): already making those personalized shots for clinical trials. Earlier today, we caught up with Stefan Bansell, Moderna's CEO. Take a look.
- 33:06
- Unidentified speaker (speaker_0): Stefan, welcome to the show on a very big day for you.
- 33:11
- Unidentified speaker (UNKNOWN): Yeah,
- 33:11
- Unidentified speaker (speaker_1): thank you, Jim, for having me.
- 33:13
- Unidentified speaker (UNKNOWN): Well,
- 33:13
- Unidentified speaker (speaker_0): I've got to tell you, I've been following your progress. And first, I want to just cover the numbers. You're made you're doing so much better. You've got uh the best flu shot that I can tell. You're doing uh COVID vaccines. People are telling me they're the ones that don't hurt and don't make you sick. So you've done some traditional things that are really just making you a lot of money,
- 33:32
- Unidentified speaker (speaker_0): correct?
- 33:34
- Unidentified speaker (UNKNOWN): Yeah,
- 33:34
- Unidentified speaker (speaker_1): I mean, we have already really invested on our infectious disease business, you know, historically. that's where we started our first product. But we've never slept on our laurels. You know, the M Nextpike product, which is the new COVID vaccine, is not only new because of a strain, which of course we have to do to give you the best protection, but we totally re engineered the product. It's a new product, like a two point zero
- 33:54
- Unidentified speaker (speaker_1): COVID shot. And the dose is one fifth of the dose those of what we had initially. So that's why the side effect is much better.
- 34:01
- Unidentified speaker (speaker_0): All right, that's the one I've got to get. Now, I I just wanna I usually don't do this, but I want to get personal for a second. My daughter uh had melanoma bad.
- 34:11
- Unidentified speaker (UNKNOWN): Oh,
- 34:11
- Unidentified speaker (speaker_1): I'm sorry.
- 34:12
- Unidentified speaker (speaker_0): No, but listen, listen, your hope, her hope is that your vaccine can make it so she can go back outside and lead a normal life and perhaps have a greater chance of it being cut back. So we're following this thing intensely with everything that I can't read the journal and
- 34:32
- Unidentified speaker (speaker_0): doing the journal and understand. But can you tell us where this is? Because you are the hope for tens of thousands of people.
- 34:40
- Unidentified speaker (UNKNOWN): Oh,
- 34:41
- Unidentified speaker (speaker_1): you're very kind. Well, as you know, we've been working on 10 years on this idea. Can you teach the immune system of a patient
- 34:49
- Unidentified speaker (UNKNOWN): how
- 34:49
- Unidentified speaker (speaker_1): to recognize the cancer of a patient and to go eat the cancer. That was the basic idea. And as you I'm sure read, a lot of people thought it was undoable.
- 34:59
- Unidentified speaker (UNKNOWN): And
- 34:59
- Unidentified speaker (speaker_1): it's true that the track record of cancer vaccine behind us was not very good.
- 35:04
- Unidentified speaker (UNKNOWN): But
- 35:04
- Unidentified speaker (speaker_1): we thought with the progress we had made in MRNA, with what we learned with infectious disease vaccine, that our approach had a serious chance. And we took that chance and to be fair, MERC Merck was a fantastic partner
- 35:15
- Unidentified speaker (speaker_1): to take that chance and that risk with us. And what it does basically is when somebody has cancer,
- 35:22
- Unidentified speaker (UNKNOWN): you
- 35:22
- Unidentified speaker (speaker_1): take a biopsy of a tumor, you take a blood drop of the blood, and then you sequence, you next gen sequence, you read all the letters of a DNA of a cancer and the healthy cell, you send them to the cloud, and you compare letter by letter where is the mutation, where is the cancer, because what we know today is cancer. is a disease of DNA, mutation
- 35:42
- Unidentified speaker (speaker_1): of DNA. And then what we do is we individualize, and I'm just behind me, we basically individualize a we make a product for one human at a time where we put in a cassette of one mRNA molecule, 34 mutation of the cancer of that patient. It's injected in intramuscular every three weeks for nine doors. And as you know,
- 36:02
- Unidentified speaker (speaker_1): you saw the data. recently. The data is fantastic. I mean, compared to ketudra, which is an amazing drug in melanoma, nobody has been able since 2018 to do better than ketudra in melanoma. Several companies tried, there were three phase three that failed. But we were able to show a 42% improvement for patients.
- 36:22
- Unidentified speaker (speaker_1): And what is even more remarkable, if you look at a phase two study where we have five years of data. the phase three had only two years of data so far. We'll, of course, share more data as we get the data. We show that the data improves over time. Why? Because the T cell we created in your body, because of our mRNA, have memory. They stay with you to
- 36:41
- Unidentified speaker (speaker_1): fight cancer coming back.
- 36:43
- Unidentified speaker (speaker_0): Wow. Well, uh, dare I ask when? Uh, we're all waiting. Uh we had. have uh oncologists that we check with. They want to be sure that things are right before we plunge in. When do you think?
- 36:59
- Unidentified speaker (speaker_1): So, as we've said, we've got partners at Merck. We are working very, very deliberately to try to get the filing to the FDA before the end of the year. And then we're expecting, I think, uh, assuming a good review by the regulators, that we should be able in 2027 to get the product available. to Americans.
- 37:16
- Unidentified speaker (UNKNOWN): Well,
- 37:16
- Unidentified speaker (speaker_0): I'm so glad. I mean, I think if you don't have it or you don't even look, you can go to the Reddit page for the melanomies. You can feel for what people have. But as a parent and the daughter, we are uh I'd never create false hopes for for cancer. Lost my mom for kidney cancer, very, very young. I know that those who create false hopes are not good. You are have
- 37:36
- Unidentified speaker (speaker_0): done the opposite. You've not played it high. you have waited and waited. How about other cancers? Are there hopes for it without getting too far ahead and making feel people feel that there's a magic bullet out there?
- 37:51
- Unidentified speaker (speaker_1): Sure, and I agree with you, Jim. It's very important. Uh people are suffering with cancer. It's very important for them and the family not to have false hope. So, what we're doing beyond melanoma is we have studies on ongoing in five different tumor types, including lung cancer. In lung, we're both looking at people that have stage two or three of lung disease. But
- 38:11
- Unidentified speaker (speaker_1): we're also trying in tismeran, that's the name of our medicine, in tismeran by itself in people that have stage one lung cancer. Because we think given it has a very good safety profile of our medicine, it could potentially be used earlier in disease to help people get back to normal life without sometimes the terrible side effects of
- 38:31
- Unidentified speaker (speaker_1): cancer treatment. So we should get data in kidney cancer pretty soon, either end of this year or next year. Those are event-driven studies when people have recurrence of disease. So of course, we do not control the timing. The one after should be bladder cancer, and the one after should be lung. So when we have the data like we've always done. we will
- 38:51
- Unidentified speaker (speaker_1): share the data with the community, including the medical community, so we can review the data. Last night, the New England Journal of Medicine, as you know, the most prestigious journal, uh, released the full data set with all the appendix. So all the melanoma doctors can look at the data and understand what the product can do and what the product doesn't do. And that's where
- 39:11
- Unidentified speaker (speaker_1): we are. And we're going to keep investing in the science because, as you know, some. software is part of the drug because we have to select from hundreds of thousands of mutations, 34 that goes in the cassette. We think we can learn by going and mining the data in a phase three study and figure out what we can tweak in the software, what was working well in the software,
- 39:31
- Unidentified speaker (speaker_1): what maybe can we improve so that we can potentially even improve that success rate. Again, it's an hypothesis. We need to overwork and look at the data. But I'm really believing that because of the progress that the medical field is making and because of the access of AI, when you can look at all those data, think about it, a thousand one hundred patients. That's a
- 39:51
- Unidentified speaker (speaker_1): lot of data when you look at all the T cell and uh the biomarkers and so on. But looking at that with big data, this will we should be able to get insight and then to have a discussion with the regulators is is that way to upgrade the software.
- 40:05
- Unidentified speaker (speaker_0): Well, look, congratulations and thank you for helping everyone who has this disease and their family members. Uh we all look forward, after that New England Journal of Medicine, to start getting lined up and getting our doctors to be aware. Uh remarkable job. I remember when I met you, you said this could happen, and then we got way laid by COVID, of
- 40:25
- Unidentified speaker (speaker_0): which you helped solve. But uh this is nothing short of remarkable, and I want to thank you uh for everything you've done, not just for the shareholders, but for the parents and for the patients. Good to see you, Stefan.
- 40:37
- Unidentified speaker (UNKNOWN): Thank
- 40:37
- Unidentified speaker (speaker_1): you so much for very kind.
- 40:38
- Unidentified speaker (speaker_0): Absolutely. That's Stefan Benselli. He's the smoderna CEO at a remarkable moment and a great shareholder meeting.
- 40:46
- Unidentified speaker (speaker_3): Coming up, you've got questions, claimers Klaimers got the answers. Get charged up. for a fast fire lightning round next.
- 41:02
- Unidentified speaker (speaker_0): It is time to seven the light round cursor is quote.
- 41:06
- Unidentified speaker (speaker_0): Bye bye bye so sense of an hour. Stop questions.
- 41:11
- Unidentified speaker (UNKNOWN): And
- 41:11
- Unidentified speaker (speaker_0): then the lightning round is over. Are you ready, Ski? Skeet? Dad told Hello,
- 41:14
- Unidentified speaker (UNKNOWN): me.
- 41:15
- Unidentified speaker (speaker_0): I'm quite remembering this over Dick in Virginia. Dick.
- 41:18
- Unidentified speaker (UNKNOWN): Hi,
- 41:19
- Unidentified speaker (speaker_1): Jim.
- 41:19
- Unidentified speaker (UNKNOWN): I'm a
- 41:20
- Unidentified speaker (speaker_0): club member
- 41:21
- Unidentified speaker (speaker_1): and I just got your book in the mail. Yay!
- 41:23
- Unidentified speaker (speaker_0): Oh, thank you. Thank you. Let's go to work.
- 41:26
- Unidentified speaker (UNKNOWN): Yeah,
- 41:27
- Unidentified speaker (speaker_1): I I found a s a stock. It's a it's called Combolt. They're in the data
- 41:33
- Unidentified speaker (UNKNOWN): recovery Recovery
- 41:33
- Unidentified speaker (speaker_1): to the business. Um,
- 41:35
- Unidentified speaker (UNKNOWN): any
- 41:36
- Unidentified speaker (speaker_1): of your thoughts on
- 41:37
- Unidentified speaker (UNKNOWN): it?
- 41:37
- Unidentified speaker (speaker_0): I saw the CEO. on dayside. That's what we call the watching TV during the daytime. And he was excellent. I thought he did a very good job. I thought he made a good case for a stock, even though it's up a lot. I think it's cool call. Good call by you. Jeffrey in Massachusetts. Jeffrey!
- 41:53
- Unidentified speaker (speaker_1): What's up, my man? How are you?
- 41:56
- Unidentified speaker (speaker_0): I'm
- 41:56
- Unidentified speaker (UNKNOWN): doing
- 41:56
- Unidentified speaker (speaker_0): well, Chief. How about you? Good to have you on a
- 41:58
- Unidentified speaker (UNKNOWN): show.
- 41:59
- Unidentified speaker (speaker_0): Not
- 41:59
- Unidentified speaker (speaker_1): too bad.
- 42:00
- Unidentified speaker (speaker_0): Excellent.
- 42:01
- Unidentified speaker (UNKNOWN): So
- 42:01
- Unidentified speaker (speaker_1): this stock I've got is down nearly 48% year to date. Bright horizons, BFAM. Fast thoughts?
- 42:08
- Unidentified speaker (speaker_0): Well, it's a very expensive stock, but that typically means to me the earnings aren't gonna come through. I don't want you to mess around with it. I don't. I'm not done. That's ridiculous. I feel like I take it like one call. Let's go to Dennis in New York. Dennis.
- 42:20
- Unidentified speaker (speaker_3): Dennis from Hampton Bayes, Jim. Big fan. Thank you.
- 42:24
- Unidentified speaker (UNKNOWN): I'm
- 42:24
- Unidentified speaker (speaker_0): my
- 42:24
- Unidentified speaker (UNKNOWN): executive producer producer's from Hampton Bayes. I'm gonna go to big. do a big shout
- 42:27
- Unidentified speaker (speaker_0): out to her. Regina. Well, I'm sorry, go ahead.
- 42:30
- Unidentified speaker (speaker_1): Texas Pacific land.
- 42:32
- Unidentified speaker (UNKNOWN): You know,
- 42:32
- Unidentified speaker (speaker_0): I'm not really into the oil stocks, and we used boy, we made a big deal about that stock when it was the right time, and I'm glad we got off that horse. I'm gonna say no to Texas Pacific. And that led to the conclusion of the Lightning Round.
- 42:48
- Unidentified speaker (UNKNOWN): The
- 42:48
- Unidentified speaker (speaker_3): Lightning Round is sponsored by Charlie. Charles Schwab.
- 42:53
- Unidentified speaker (speaker_3): Coming up as we wrap up another busy day, Kramer has some final thoughts. Don't miss his no huddle. Next.
- 43:03
- Unidentified speaker (speaker_1): Booyah, Jim. Your integrity makes you the Booyah Saint of Wall Street. Booyah, Jimmy Chill. Booyah,
- 43:12
- Unidentified speaker (UNKNOWN): Jimmy
- 43:13
- Unidentified speaker (speaker_1): Chill.
- 43:14
- Unidentified speaker (speaker_1): Booyah, Jim.
- 43:15
- Unidentified speaker (speaker_0): Quadruple. That's a lot of booyas.
- 43:29
- Unidentified speaker (speaker_0): Look, uh, I'm sad. I did love the guy in the leather jacket. I liked him from the first time I interviewed him in 2010 when the stock was around 30 cents, counting accounting for the various spots. splits over the years, called it a Kramer Fave. I continued to hear more and more about the company in the years that followed, including from the CEO of Audi North America, who told me that NVIDIA's chips were the secret behind his
- 43:49
- Unidentified speaker (speaker_0): self-driving technology. At the time, everyone just thought this was a gaming chip company. In 2017, frustrated that people didn't know about the company, I renamed my dog Everest, changing it to NVIDIA, to call attention to the incredible. company that NVIDIA was.
- 44:05
- Unidentified speaker (UNKNOWN): That
- 44:06
- Unidentified speaker (speaker_0): late Mutt, half pit bull, half whatever, got a lot of people's attention, including Jensen. He made a badge for NVIDIA to get into headquarters anytime he wanted to. That's kind of Jensen's pixie humor. A couple months later is when I bought the stock from my Chapel Trust for the first time. The stock That was around four bucks.
- 44:22
- Unidentified speaker (UNKNOWN): But
- 44:22
- Unidentified speaker (speaker_0): I only fully realized how special this company was after I spent some time at headquarters. and saw amazing things. And not just the employee badges Jensen made for the dog. Things like robots being rewarded for picking up jello. Things like a machine drawing a Saison seascape in 10 seconds, when I knew he never painted one, but I asked the machine to do it anyway. The colors were
- 44:42
- Unidentified speaker (speaker_0): spot on, shading amazing. I talked about what I say at NVIDIA and almost at what I saw at NVIDIA in almost every day for weeks. on this show and on Squawk on the Street. You know, at one point my partner David told me he was sick of my touting NVIDIA. I didn't care. I kept doing
- 45:01
- Unidentified speaker (UNKNOWN): it. There
- 45:02
- Unidentified speaker (speaker_0): were so many other things Chenshin showed me over the years, especially when I started getting going to the company's GTC event every year. Each time I went out, I learned some new things. Sometimes they were hysterical, sometimes they were somber, but they were always brilliant.
- 45:15
- Unidentified speaker (UNKNOWN): He
- 45:15
- Unidentified speaker (speaker_0): introduced me to the neoclouds like Nebias and I ran. He made me realize that his partners like Dell and HPE were obvious buys as the AI era began. These stocks made fortunes for people. I saw robots make hospital corners, 10 bar, really super stuff. His keynotes are they were dazzling. But one of the most meaningful things he did was attend a lunch right here at the
- 45:35
- Unidentified speaker (speaker_0): New York Stock Exchange for CMBC CMEC Investing Club members. most of whom had become millionaires because they bought the stock of NVIDIA. We had 70 guests. I wanted a group picture. He said no. He wanted individual selfies with individual people, every one of them. All regular people like you, club members who believed. I saw his graciousness repeatedly. I rejoiced in
- 45:55
- Unidentified speaker (speaker_0): it.
- 45:56
- Unidentified speaker (UNKNOWN): He
- 45:56
- Unidentified speaker (speaker_0): was always so polite and well-meaning. well meaning. I introduced my wife to him. He's one won of just a few execs in the 22 twenty two years I've been doing this that I did that.
- 46:03
- Unidentified speaker (UNKNOWN): She
- 46:03
- Unidentified speaker (speaker_0): thought he was terrific. He took her seriously, asking plenty of questions, right in her eyes, looked at her, showing amazing respect. She was impressed. She thought he was sensational. Over the last couple of years, I saw Jensen all over the place. I thought he was kind of changing. He's having a grand time, why not? Seemingly celebrating and paling around with the president as much as he was working. Although that was just an impression.
- 46:24
- Unidentified speaker (speaker_0): At one point I saw him sign a woman's shirt in a place that I thought was. inappropriate.
- 46:28
- Unidentified speaker (UNKNOWN): Well,
- 46:28
- Unidentified speaker (speaker_0): maybe that was the new, more successful, cooler, why not Florent Jensen? But he was right back to being serious at the next GTC in San Jose.
- 46:37
- Unidentified speaker (UNKNOWN): At
- 46:37
- Unidentified speaker (speaker_0): all times, I admit I was thrilled to spend time with him. Just thrilled. You know, I tried not to idolize him for his brilliance. I tried not to put him on a pedestal for spectacular innovations, and I defended everything, including his push to sell previous generation chips to China. Chinese customers. Because I thought he was earnest when he said it was in the best interest of our country to hook Chinese customers on the NVIDIA
- 46:57
- Unidentified speaker (speaker_0): ecosystem rather than have them build their own. I still do. Never once did I think that there might be other motivations, and I still really hope that's not the case.
- 47:06
- Unidentified speaker (UNKNOWN): In
- 47:06
- Unidentified speaker (speaker_0): the end, unlike so many others, I wanted everything negative said about him stopped. At the very least, give him a chance to explain. Don't take this fine man a point. apart. He's too important to our nation's future. His body of work was too stellar. We can't afford to lose him if we are going to be the world's AI leader.
- 47:23
- Unidentified speaker (UNKNOWN): But
- 47:24
- Unidentified speaker (speaker_0): it was not to be. The man in the leather jacket let his wife down.
- 47:29
- Unidentified speaker (UNKNOWN): He
- 47:29
- Unidentified speaker (speaker_0): let his kids down. He let his company down. He let his co-workers down. He let his shareholders down. He let his country down. Sadly, he let me, a person who just loved the guy
- 47:41
- Unidentified speaker (UNKNOWN): down. My
- 47:42
- Unidentified speaker (speaker_0): talking video died a half dozen years ago. Come to think of it, maybe he was the only one who didn't get let down by the man in the leather jacket. He just didn't live long enough to see it.
- 47:56
- Unidentified speaker (UNKNOWN): I
- 47:56
- Unidentified speaker (speaker_0): like to say that there's It's always a bull market somewhere and I promise try you I to find it just for you right here on Mad Mid Money. I'm Jim Kramer. See you next.
- 48:06
- Unidentified speaker (UNKNOWN): All
- 48:06
- Unidentified speaker (speaker_2): opinions expressed by Jim Kramer on this podcast are solely Kramer's opinions and do not reflect the opinions of CNPC or its parent company or affiliates, and may have been previously disseminated by Kramer on television, radio, internet, or another medium. You should not treat any opinion expressed by Kramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Kramer's opinions are based upon information he
- 48:26
- Unidentified speaker (speaker_2): considers. reliable, but neither CNBC nor its affiliates andor subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Mad Money Disclaimer, please visit CNBC.com forward slash madmoney disclaimer. AI is here, transforming how we work, live, and lead. And the women I talk to aren't waiting for the future, they're
- 48:45
- Unidentified speaker (speaker_2): shaping it. I'm Julia Borstin, Senior Media and Tech Correspondent at CNBC. This is CNBC Changemakers, where I talk with the female leaders transforming business as AI reshapes
- 48:57
- Unidentified speaker (speaker_0): the world.
- 48:58
- Unidentified speaker (UNKNOWN): Follow and listen
- 48:59
- Unidentified speaker (speaker_0): to CNBC Changemakers, women leading in the age of
- 49:02
- Unidentified speaker (UNKNOWN): AI, wherever you get your podcasts.
More from Mad Money w/ Jim Cramer
Mad Money: Wall Street Jargon, Cyclicals, GARP & Corrections 11/13/26
Episode discussion: Jim Cramer distinguishes cyclical from secular stocks and advises against holding REITs amid rate hikes
Speakers’ claims: Jim Cramer demystifies Wall Street jargon by contrasting cyclical stocks tied to economic cycles with secular growth companies that perform regardless of economic conditions. He recommends higher equity exposure for younger investors and suggests dollar-cost averaging into S&P 500 index funds for long-term goals. Cramer warns against holding REITs due to interest rate pressure and cautions investors against turning failed trades into long-term investments. He advocates for diversification, limiting any single sector to 20% of a portfolio, and emphasizes management execution over passive buy-and-hold strategies.
Mad Money w/ Jim Cramer 11/11/26
Episode discussion: Cramer discusses NVIDIA scandal, CoreWeave demand, Anthropic profitability, and restaurant rotation
Speakers’ claims: Jim Cramer addresses market reactions to a sex scandal involving NVIDIA CEO Jensen Huang, noting that data center stocks rallied despite the news. He highlights an interview with CoreWeave CEO Michael Intrator, who claims compute demand is ten times oversubscribed for 2027 and that older NVIDIA chips are being recontracted at a premium. Cramer also analyzes Anthropic's financials, pointing out adjusted profitability driven by non-cash charges and massive future infrastructure spending plans. The episode shifts to a rotation into restaurant stocks like Wingstop and Shake Shack, followed by an interview with Teva Pharmaceutical CEO Richard Francis regarding the company's shift to biopharma. The segment concludes with a Lightning Round featuring recommendations for Alibaba and Energy Transfer, and rejections for DraftKings and Netskope.